Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Subbiah Jeeva"'
Autor:
Bo Ryoung Park, Ki-Hye Kim, Tatiana Kotomina, Min-Chul Kim, Young-Man Kwon, Subbiah Jeeva, Yu-Jin Jung, Noopur Bhatnagar, Irina Isakova-Sivak, Daria Mezhenskaya, Larisa Rudenko, Bao-Zhong Wang, Sang-Moo Kang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza A virus contains an ion channel protein M2 conserved extracellular domain (M2e), a target for developing universal vaccines. Here we generated reassorta
Externí odkaz:
https://doaj.org/article/de27ac60c5a6402b8c6c3bb5e7a6fea3
Publikováno v:
Vaccines, Vol 9, Iss 9, p 965 (2021)
With the success of COVID-19 vaccines, newly created mRNA vaccines against other infectious diseases are beginning to emerge. Here, we review the structural elements required for designing mRNA vaccine constructs for effective in vitro synthetic tran
Externí odkaz:
https://doaj.org/article/a32a5485ee6f4f3cae37db81ddb506cf
Publikováno v:
Cells, Vol 10, Iss 6, p 1412 (2021)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gave rise to the coronavirus disease 2019 (COVID-19) pandemic. A strong correlation has been demonstrated between worse COVID-19 outcomes, aging, and metabolic syndrome (MetS), which is
Externí odkaz:
https://doaj.org/article/28c058d4df9b4efd93b49fe0b44e3df5
Autor:
Ki-Hye Kim, Noopur Bhatnagar, Subbiah Jeeva, Judy Oh, Bo Ryoung Park, Chong Hyun Shin, Bao-Zhong Wang, Sang-Moo Kang
Publikováno v:
Vaccines, Vol 9, Iss 4, p 316 (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be expanding the pandemic disease across the globe. Although SARS-CoV-2 vaccines were rapidly developed and approved for emergency use of vaccination in humans, supply and prod
Externí odkaz:
https://doaj.org/article/8acbbb28d674473f8d668fa75cdc092d
Publikováno v:
Vaccines, Vol 8, Iss 4, p 716 (2020)
Respiratory syncytial virus (RSV) is one of the most important pathogens causing significant morbidity and mortality in infants and the elderly. Live attenuated influenza vaccine (LAIV) is a licensed vaccine platform in humans and it is known to indu
Externí odkaz:
https://doaj.org/article/25c2a5b414564682b21a1504107ce0e3
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0184935 (2017)
Crimean Congo hemorrhagic fever, a zoonotic viral disease, has high mortality rate in humans. There is currently no vaccine for Crimean Congo hemorrhagic fever virus (CCHFV) and chemical interventions are limited. The three negative sense genomic RNA
Externí odkaz:
https://doaj.org/article/7b1edeb3773e4aa5a9c3f2ef07dad485
Autor:
Sailaja Gangadhara, Young-Man Kwon, Subbiah Jeeva, Fu-Shi Quan, Baozhong Wang, Bernard Moss, Richard W. Compans, Rama Rao Amara, M. Abdul Jabbar, Sang-Moo Kang
Publikováno v:
Vaccines, Vol 5, Iss 4, p 52 (2017)
Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is considered as a promising vaccination approach against human immunodeficiency virus (HIV-1). To further enhance the efficacy of DNA-rMVA vaccination,
Externí odkaz:
https://doaj.org/article/3c2fb4ee3f904b5dab57d5345c3f6c6a
Autor:
Kim, Ki-Hye, Bhatnagar, Noopur, Subbiah, Jeeva, Liu, Rong, Pal, Surya Sekhar, Raha, Jannatul Ruhan, Grovenstein, Phillip, Shin, Chong Hyun, Wang, Bao-Zhong, Kang, Sang-Moo
Publikováno v:
In Virology July 2024 595
Autor:
Oh, Judy, Subbiah, Jeeva, Kim, Ki-Hye, Park, Bo Ryoung, Bhatnagar, Noopur, Garcia, Karla Ruiz, Liu, Rong, Jung, Yu-Jin, Shin, Chong-Hyun, Seong, Baik-Lin, Kang, Sang-Moo
Publikováno v:
In Virology September 2022 574:37-46
Autor:
Dhasarathan, P., AlSalhi, Mohamad S., Devanesan, Sandhanasamy, Subbiah, Jeeva, Ranjitsingh, A.J.A., Binsalah, Mohammed, Alfuraydi, Akram A.
Publikováno v:
In Journal of Infection and Public Health December 2021 14(12):1848-1853